AS trials suggest they can treat ever more illnesses and more people use them to slim down, it is clear weight loss jabs are ...

The president’s campaign to arrest and deport thousands of immigrants has turned cities run by his political enemies into ...

FDA has previously agreed on the design of this 300-patient randomized, placebo-controlled confirmatory Phase 3 trial, and the 12-month primary endpoint of pain reduction as an approvable indication.

Novo Nordisk and Eli Lilly have dominated the market until now, but this year is set to bring oral drugs, generics, and a ...

Here's what San Antonio doctors say about the widespread use of GLP-1 medications for obesity, diabetes and other conditions.

Young women are flocking to a glitzy new clinic in Midtown Manhattan to get bigger breasts... without going under the knife.

The SFDA is the first regulatory authority globally to grant conditional approval for this medication for the treatment of NSCLC ...